ENHANCED EXTERNAL COUNTER PULSATION MC2 *

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2002-12-20 for ENHANCED EXTERNAL COUNTER PULSATION MC2 * manufactured by Foshan Life Sciences.

Event Text Entries

[308638] Developed severe dyspnea during treatment and taken to hosp. Admitted and intubated.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2435300-2002-00014
MDR Report Key434013
Report Source05,06
Date Received2002-12-20
Date of Report2002-12-11
Date of Event2002-08-21
Date Mfgr Received2002-11-25
Device Manufacturer Date2000-06-01
Date Added to Maude2002-12-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactTHOMAS VARRICCHIONE
Manufacturer Street180 LINDEN AVE.
Manufacturer CityWESTBURY NY 11590
Manufacturer CountryUS
Manufacturer Postal11590
Manufacturer Phone5169974600
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameENHANCED EXTERNAL COUNTER PULSATION
Generic NameDEVICE, COUNTER-PULSATING EXTERNAL
Product CodeDRN
Date Received2002-12-20
Model NumberMC2
Catalog Number*
Lot Number*
ID Number*
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrN
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key422966
ManufacturerFOSHAN LIFE SCIENCES
Manufacturer Address6 HARBOR RD FOSHAN CITY, GUANG DONG, P.R. CH 528000
Baseline Brand NameENHANCED EXTERNAL COUNTERPULSATION
Baseline Generic NameEECP
Baseline Model NoMC2
Baseline Catalog NoNA
Baseline IDNA
Baseline Device FamilyDEVICE, COUNTER-PULSATING, EXTERNAL
Baseline Shelf Life [Months]NA
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK940264
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2002-12-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.